Cargando…
Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis
BACKGROUND: The treatment of patients with advanced gastric cancer remains a most challenging task in the clinical practice. Recently, targeted therapies have significantly impacted the treatment strategy for many common malignancies. The use of trastuzumab, a monoclonal antibody against human epide...
Autores principales: | Wang, Hong-Bo, Liao, Xiao-Feng, Zhang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682803/ https://www.ncbi.nlm.nih.gov/pubmed/29095284 http://dx.doi.org/10.1097/MD.0000000000008437 |
Ejemplares similares
-
Clinicopathological features and prognosis of coexistence of gastric gastrointestinal stromal tumor and gastric cancer
por: Liu, Zhen, et al.
Publicado: (2016) -
Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis
por: Cheng, Fei, et al.
Publicado: (2019) -
Reduced NM23 Protein Level Correlates With Worse Clinicopathologic Features in Colorectal Cancers: A Meta-Analysis of Pooled Data
por: Yang, Tian, et al.
Publicado: (2016) -
Efficacy and safety of treatment with or without pertuzumab for HER2-positive breast cancer: A meta-analysis
por: Chen, Xuan, et al.
Publicado: (2023) -
The clinicopathological features and prognostic factors of gastric squamous cell carcinoma
por: Dong, Caixia, et al.
Publicado: (2016)